Introduction
Obesity is a major risk factor for developing type 2 diabetes 1 and may be related to the increased susceptibility to insulin resistance in obese compared to lean subjects. Insulin resistance in skeletal muscle of obese individuals has been observed. 2, 3 However, the role of adipose tissue in inducing whole body insulin resistance is still unclear. Based on studies where radiolabelled glucose was administered intravenously, adipose tissue was thought to take up only a small percentage of the total glucose. 4, 5 In these studies, radioactivity in adipose triglycerides was measured as an in vivo indicator of glucose metabolism. However, in vitro studies of the glucose metabolites of adipose tissue, demonstrated that 70% are released as lactate and 10% as CO 2 , whereas only 20% of the glucose is stored as triglyceride. 6 This suggests that incorporation of radioactive glucose into lipid in vivo under-represents the capacity of adipose tissue to utilize glucose by about 80%. Adipose tissue could therefore play an important role in whole-body glucose homeostasis, particularly in obese individuals.
A stronger correlation is observed between visceral adipose tissue mass and insulin resistance than with overall obesity itself. 7, 8 Furthermore, individuals with central obesity are more likely to develop type 2 diabetes than those individuals who are equally overweight, but with a peripheral distribution of body fat. 9, 10 Whether a difference in insulin-mediated glucose uptake between omental and subcutaneous adipose tissue might contribute directly to insulin resistance in obesity or central obesity has not been clarified.
In this study, basal and insulin-stimulated glucose uptake in adipose tissue explants of lean and obese subjects was compared. Furthermore, differences in insulin sensitivity between those with central obesity and those with peripheral obesity were investigated. Paired samples of omental and subcutaneous adipose tissue were taken from each patient to determine if differences in insulin sensitivity occur and whether this is affected by the level of adiposity or body fat distribution.
Subjects and methods

Subjects
The study protocol was reviewed and approved by the institutional ethical committees of the Princess Alexandra Hospital, PAH, (Brisbane, Australia) and Wesley Hospital (Brisbane, Australia). Informed consent was received from all subjects before participation. Individuals with diabetes mellitus, a history of diabetes mellitus, systemic illness or malignancy, or those on medication known to influence glucose metabolism, were excluded. Subjects had fasted overnight before adipose tissue removal. Biopsies of adipose tissue were obtained from omental and abdominal subcutaneous sites of patients undergoing elective abdominal surgery at the Wesley Hospital or PAH. Biopsies were obtained at the time of surgery and immediately transported to the laboratory in Dulbecco's Modification of Eagle's Medium (DMEM; 1000 mg=l glucose) containing 2% bovine serum albumin (BSA) (transport time 30 -40 min).
Fourteen lean, 12 overweight and 15 obese patients served as subjects. Lean subjects were defined as those with a body mass index (BMI) less than 25 kg=m 2 , overweight subjects were defined as those with a BMI between 25 and 30 kg=m 2 while obese subjects were defined as those with a BMI > 30 kg=m 2 . This is in accordance with the current World Health Organization's classification of obesity. Obese and overweight subjects were further divided into two groups according to their body fat distribution as determined by their waist-to-hip ratio (WHR). Central obesity was defined as a WHR above 0.8 in females and above 0.95 in males.
Glucose uptake Actrapid, recombinant human insulin, was purchased from Novo Nordisk Pharmaceutical (North Rocks, NSW, Australia). Whole tissue adipose explants (approximately 10 mg), excluding visible connective tissue and blood vessels, were removed from the biopsy material and placed in DMEM (1000 mg=l glucose) supplemented with 2 mm L-glutamine, 100 U=ml penicillin, 100 g=ml streptomycin and 2% BSA and incubated for 30 min at 37 C under 5% CO 2 . Medium was removed and explants were washed three times in KrebsRinger HEPES (KRH) buffer containing 1% BSA (pH 7.4) kept at 37 C. Explants were incubated in 0.5 ml KRH buffer with either 0 or 100 nM insulin for 15 min at 37 C under 5% CO 2 . Fifty micromolar 2-deoxyglucose, 0.04 mM [ C. We found a maximally effective stimulation of glucose transport occurred at 20 min using 100 nM insulin (data not shown).
Following incubation explants were washed in ice-cold KRH buffer to stop transport and washed a further four times in the same buffer in order to remove unbound label. Explants were blotted and then weighed using Mettler scales. 3 H and 14 C radioactivity were determined by scintillation counting using a Minaxa Scintillation counter from Packard. Basal glucose uptake was taken as 2-deoxyglucose uptake in the absence of insulin. In each experiment, points were determined in triplicate. Data was expressed as rmol 2-deoxyglucose=mg wet weight. The small amount of extracellular 2-deoxyglucose remaining was corrected from the [ 14 C]-inulin remaining in the sample. The reliability coefficient of the assay was 0.96 (n ¼ 8).
Presentation of the results and statistical analysis
Results were expressed as means AE standard error of the mean (s.e.m.). A one-way ANOVA was used to test whether age,
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Results
The lean, overweight and obese groups were well matched for age and WHR (Table 1) . Insulin stimulation of 2-deoxyglucose transport in adipose tissue explants in obese and overweight compared to lean subjects was investigated. Lean subjects demonstrated an increase in 2-deoxyglucose transport over basal in omental (P < 0.0001) and subcutaneous adipose tissue (P < 0.0001) with insulin. In contrast to the lean subjects, there was no significant stimulation of 2-deoxyglucose transport by insulin over basal in tissue from the obese or overweight subjects (Figure 1 a,b) . Accordingly, insulin-stimulated 2-deoxyglucose transport was significantly lower in both omental and subcutaneous adipose tissue of obese and overweight subjects compared to lean (Figure 1 a,b), with P-values ranging from 0.0001 to 0.025. Basal 2-deoxyglucose uptake was reduced significantly in obese compared to lean subjects in both omental (P ¼ 0.013) and subcutaneous adipose tissue (P ¼ 0.044; Figure 1 a,b). In order to look for differences in glucose uptake in omental compared with subcutaneous adipose tissue, 2-deoxyglucose transport was measured in both depots from each patient. There was a trend for higher 2-deoxyglucose uptake in omental compared with subcutaneous adipose tissue under all circumstances, reaching statistical significance in the lean subjects under basal conditions (P ¼ 0.002, Figure 2 ). However, no significant differences were found when insulin action was expressed as fold increase over basal (data not shown).
We also looked for depot specific differences between glucose uptake in the lean, overweight and obese groups. In adipose tissue obtained from overweight and obese subjects insulin-stimulated glucose uptake was reduced in both depots to a similar extent despite higher overall basal glucose uptake in omental tissue (Figure 2 ). In samples from overweight subjects, insulin-stimulated 2-deoxyglucose was reduced by 52% in omental adipose tissue and by 55% in subcutaneous adipose tissue samples compared to lean. In obese subjects insulin-stimulated 2-deoxyglucose was reduced by 71% in both omental and subcutaneous adipose tissue compared to lean.
Overweight and obese subjects were classed as centrally or peripherally obese according to their WHR. The physical characteristics of the central obesity and peripheral obesity groups are shown in Table 2 . The two groups were well matched for BMI and age. 
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Adipose tissue glucose uptake and obesity M Stolic et al Glucose uptake in adipose tissue explants taken from patients with central obesity was investigated and compared with those from patients with peripheral obesity. There was reduced insulin action when expressed as fold increase over basal in omental adipose tissue in those with central obesity compared to those with peripheral obesity (P ¼ 0.024, Figure  3) . No difference in insulin-stimulated 2-deoxyglucose uptake of subcutaneous adipose tissue was demonstrated. Basal 2-deoxyglucose uptake in either omental or subcutaneous adipose tissue did not differ significantly between subjects with peripheral and central obesity (data not shown).
Discussion
Obesity, in particular visceral obesity, is associated with an increase in insulin resistance. 11, 12 To investigate the basis of this association, we have utilized adipose tissue biopsies to compare basal and insulin stimulated glucose uptake in lean and obese subjects, as well as those with central or peripheral obesity. Regional variation in insulin sensitivity was also investigated.
Our results demonstrate that omental and abdominal subcutaneous adipose tissue from obese and overweight subjects without diabetes were not responsive to insulin. Maximally insulin-stimulated 2-deoxyglucose transport was significantly lower in adipose tissue samples from obese subjects compared to those from lean subjects. These results suggest that being overweight or obese is associated with insulin resistance in adipose tissue. Other groups have also found reduced whole body insulin sensitivity in vivo, reduced muscle insulin sensitivity in vitro 2,13 and reduced insulin sensitivity in isolated adipocytes in vitro in obesity. 14 -16 We have additionally investigated the action of insulin in adipose tissue of overweight subjects with a BMI between 25 and 30 kg=m 2 and demonstrated insulin resistance at a lower BMI than previously expected or reported.
The literature remains controversial as to whether obesity influences basal (non-insulin-mediated) glucose transport in adipose tissue. Some groups have shown reduced basal Comparison of 2-deoxyglucose transport (pmol=mg wet weight adipose tissue) in omental and subcutaneous adipose tissue in lean, overweight and obese subjects under (a) basal ( * P ¼ 0.002) and (b) insulin-stimulated conditions. Columns represent mean values and s.e.m. Data was analysed using the repeat measures analysis of variance. 
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In comparison to isolated human adipocytes, explants offer several advantages in glucose transport studies. Importantly, explants are more likely to reflect in vivo functions of human adipose tissue. The tissue is relatively intact, making it possible to consider the influence of stromal factors on glucose uptake. There is no selective loss of certain types of adipocytes (such as small or large ones) in the tissue preparation, which may otherwise bias results as cell size shows important physiological effects. 18 Furthermore, explants eliminate the need for collagenase digestion to isolate cells -a process known to influence glucose uptake. 19 In contrast, the isolated fat cell preparation is a homogenous sample where the metabolic response is rapid and pronounced. Glucose uptake can be 2 -5 times higher in isolated adipocytes than that found in vivo. 20 We would therefore expect a lower-fold increase in response to insulin in explants compared to isolated adipocytes. In view of these factors, our results are comparable with the results obtained using isolated human adipocytes. 15, 21, 22 For example, Garvey et al 15 reported a 1.7-fold increase in glucose uptake in lean subjects and a 1.3 fold increase in obese subjects and Marette et al 22 reported a 1.3 -fold increase in severely obese women. Only a few studies have examined differences in insulinmediated glucose uptake between intra-abdominal and subcutaneous adipose tissue. In this study, there was a trend for higher 2-deoxyglucose uptake in omental compared to subcutaneous adipose tissue in lean subjects. Whether insulin resistance is adipose-depot specific in the overweight or obese was investigated. No statistically significant differences were found in insulin responsive glucose uptake in lean, overweight or obese subjects between omental and abdominal subcutaneous sites, although the trend for higher basal glucose uptake in omental adipose tissue continued. These findings are in agreement with the study performed by Marette et al 22 which examined regional differences between omental and abdominal subcutaneous tissue in nine massively obese subjects. In this study no difference between insulin-responsive glucose transport between omental and abdominal subcutaneous adipose tissue was found, despite a trend for higher basal glucose transport in omental tissue. Interestingly, this is in contrast to the marked site-specific differences in insulin action seen in lipolysis between omental and subcutaneous adipose tissue with higher rates of lipolysis reported in omental compared with subcutaneous. 23, 24 Few studies, however, have examined depot-specific effects in both lipolysis and glucose uptake. Marette et al 22 performed both glucose uptake and lipolysis studies on the same patients and found no site-specific differences in glucose uptake, yet reported higher insulin-induced inhibition of lipolysis in subcutaneous adipose tissue compared to omental. They also reported no significant difference in GLUT4 expression between omental and subcutaneous adipose tissue. In contrast, insulin receptor substrate-1 (IRS-1) and phosphotyrosine associated phosphatidylinositol (PI) 3-kinase activity have been reported to be reduced up to $50% in omental compared with subcutaneous adipose tissue. 24 Complete inhibition of PI3-kinase activity inhibits both the antilipolytic effect of insulin and insulin-stimulated glucose uptake. 25 There is evidence to suggest, however, that only minimal levels of PI3-kinase are necessary for maximal insulin-stimulated glucose transport. For example, Venable et al 26 demonstrated that overexpression of protein-tyrosine phosphatase-1B (PTP1B) reduced IRS-1 and phosphotyrosine associated PI3-kinase activity by 50 -60% without any effect on glucose uptake. Furthermore Staubs et al 27 showed that pre-treatment with platelet-derived growth factor (PDGF) led to a marked 80 -90% reduction of anti-phosphotyrosine and IRS-1 associated PI3-kinase activity but did not effect GLUT4 translocation or glucose transport. Although it appears that PI3-kinase activity is not rate-limiting for insulin-stimulated glucose transport, the effect of reduced PI3-kinase activity on lipolysis is yet to be determined. These results, however, illustrate the dichotomous actions of key insulin signalling molecules in the metabolic effects of insulin.
To the best of our knowledge, no studies examining differences in glucose transport between omental and subcutaneous adipose tissue in subjects with central obesity have yet been reported. In the patients with central obesity, as determined by WHR, an increase in insulin resistance in omental adipose tissue but not in subcutaneous adipose tissue was seen. The mechanism for the increased insulin resistance in the omental depot, observed in this study, in those with central obesity requires further investigation. This insulin resistance may be an acquired defect related to the excess accumulation of adipose tissue mass in this store. Increased fat accumulation in obesity is a consequence of increased adipocyte size and number. 28 Increased size of adipocytes may be associated with increased insulin resistance. Visceral adipocytes may also show increased local expression of an as yet unidentified secondary factor that affects the insulin sensitivity of this region. Alternatively, predisposed subjects with an intrinsic insulin resistance in their omental adipocytes may result in these subjects developing central adiposity.
Unfortunately, there were only a small number of male subjects in our study. Whether a gender specific difference in glucose transport exists was therefore difficult to ascertain. In addition, very few studies have examined the influence of sex on adipose tissue glucose uptake, and direct comparisons with these studies to ours cannot be made due to the fact that no other studies have taken into account the influence of BMI and WHR on sex-related differences. 29, 30 In addition the effect of age on sex-related differences (including the influence of menopause) in glucose transport has not been accounted for. The possible influence of gender on the results reported here is thus difficult to predict without further study on an increased number of male subjects.
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Conclusion
Insulin resistance occurs in adipose tissue obtained from overweight as well as obese individuals. The insulin resistance occurs at a lower BMI than expected and suggests that achieving a normal BMI ( < 25 kg=m 2 ) may significantly increase human adipose tissue responsiveness to insulin. The insulin resistance of the overweight or obese subjects is not adipose-depot specific. In lean individuals insulin responsiveness of omental and subcutaneous adipose tissue was similar, but basal glucose uptake was significantly higher in omental adipose tissue. However, in obese subjects with a central distribution of adiposity insulin resistance occurs at the site of omental adipose tissue, in contrast to those with peripheral obesity. The mechanism for the increased insulin resistance in the omental depot, observed in this study, in those with central obesity requires further investigation.
These findings demonstrate the complexity of glucose disposal and insulin action in human adipose tissue, and indicate influences of BMI, anatomical depot and body fat distribution. They further indicate that basal (non-insulinstimulated) glucose uptake may have an important role in overall glucose homeostasis. The significant decrease in basal glucose uptake seen in the tissue of overweight and obese individuals is of particular interest as it suggests that the hyperinsulinaemia seen in obesity may be secondary to reduced glucose uptake by tissue in the fasting as well as the post-prandial state. The decrease in basal glucose uptake seen in the overweight and obese subjects requires further investigation.
